Aprea Therapeutics to Present at Lytham Partners Fall Investor Conference
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced that its President and CEO, Dr. Oren Gilad, will present at the Lytham Partners Fall 2024 Investor Conference on October 1.
Aprea Therapeutics to Present at Lytham Partners Fall Investor Conference Read More